跳至主要内容
临床试验/NCT02237170
NCT02237170已完成不适用

A Systems Biology Approach to Immune Monitoring in Patients With Castration-resistant Prostate Cancer Receiving SiPuleucel-T

Icahn School of Medicine at Mount Sinai3 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
3
主要终点
Change in Regulatory T cells (Tregs)

研究概览

简要总结

The purpose of this protocol is perform comprehensive immune monitoring studies in patients with castration-resistant prostate cancer receiving Sipuleucel-T in an effort to better understand the mechanism of action of this treatment.

详细描述

The primary objectives of this study are to:

  1. Establish the phenotype and frequency of circulating immune cell compartments in patients undergoing treatment with Sipuleucel-T.
  2. Determine the induction and the quality of prostate antigen-specific T cell immunity in patients undergoing treatment with Sipuleucel-T.
  3. Correlate whole-blood RNA transcript-based signatures with clinical outcomes in patients treated with Sipuleucel-T.
  4. Evaluate the cytokine and chemokine milieu in the peripheral blood pre- and post-treatment with Sipuleucel-T.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age > 18 years of age
  • Written informed consent obtained
  • Patients with castration-resistant prostate cancer who are initiating Sipuleucel-T as standard therapy
  • No prior systemic chemotherapy for metastatic prostate cancer
  • Hemoglobin > 9 mg/dl

排除标准

  • Patients unable to understand the research protocol and/or provide informed consent

结局指标

主要结局

Change in Regulatory T cells (Tregs)

时间窗: baseline and 1 year

Establish the phenotype and frequency of circulating immune cell compartments in patients undergoing treatment with Sipuleucel-T looking at the change in regulatory T cells at 1 year post treatment compared to at baseline

次要结局

  • Change in Antigen Presenting Cells(baseline and 1 year)
  • Change in Prostate Antigen-specific T Cell Immunity(baseline and one year)
  • Change in chemokine milieu(baseline and 1 year)
  • Whole-blood RNA transcript-based signatures(up to 1 year)
  • Change in cytokine milieu(baseline and 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验